Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 908 (LINC00908) is a long non-coding RNA located on chromosome 18; it encodes a 60-amino-acid regulatory peptide known as ASRPS (a small regulatory peptide of STAT3). LINC00908 and its encoded micropeptide are downregulated in triple-negative breast cancer (TNBC) and other cancers, correlating with increased tumor growth and poor prognosis. ASRPS directly binds to the coiled-coil domain of STAT3, inhibiting STAT3 phosphorylation and subsequent VEGF expression, thereby suppressing tumor angiogenesis. LINC00908 is transcriptionally regulated by estrogen receptor alpha (ERα), and its expression appears to be negatively regulated in ERα-negative tumors such as TNBC. There is emerging evidence for its potential as a therapeutic target and prognostic cancer biomarker, but no drugs are currently known to target this lncRNA or its peptide directly[1][2][3][4].
Encodes the 60-amino acid peptide ASRPS, which binds to the coiled-coil domain of STAT3, inhibiting its phosphorylation and downstream VEGF expression, resulting in decreased tumor angiogenesis[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 908 (LINC00908).